CGMP Deviations; Presence of N-nitroso-duloxetine impurity above recommended interim limit.
Classification
Class II
Status
Ongoing
Lot
Lot # DT2023003A, DT2023007A, DT2023008A, exp. date Jan-25
Date
Disclaimer: This tool indexes published US FDA drug-enforcement recall records from all countries, limited to the latest five years. A company or product not appearing here is not proof that it is compliant, approved, safe, or free of FDA action.